Literature DB >> 28261780

Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Á Sánchez-Ferro1,2,3,4,5, J Benito-León2,3,4, E D Louis6,7,8, I Contador9, J Hernández-Gallego2,3,4, V Puertas-Martín2, F Bermejo-Pareja2,3,4.   

Abstract

OBJECTIVES: Patients with Parkinson's disease (PD) and essential tremor (ET) have a higher risk of cognitive impairment than age-matched controls. Only a few small studies (11-18 subjects per group) have directly compared the cognitive profile of these conditions. Our aim was to compare the cognitive profile of patients with these two conditions to each other and to healthy individuals in a population-based study of non-demented participants.
MATERIALS AND METHODS: This investigation was part of the NEDICES study, a survey of the elderly in which 2438 dementia-free participants underwent a short neuropsychological battery. We used nonparametric techniques to evaluate whether there are differences and/or a gradient of impairment across the groups (PD, ET, and controls). Also, we performed a head-to-head comparison of ET and PD, adjusting for age and education.
RESULTS: Patients with PD (N=46) and ET (N=180) had poorer cognition than controls (N=2212). An impaired gradient of performance was evident. PD scored lower than ET, and then each of these lower than controls, in memory (P<.05) and verbal fluency (P<.001) tasks. When we compared PD and ET, the former had lower scores in verbal fluency (P<.05), whereas the later had a poorer cognitive processing speed (P<.05).
CONCLUSIONS: This large population-based study demonstrates that both conditions influence cognitive performance, that a continuum exists from normal controls to ET to PD (most severe), and that although deficits are in many of the same cognitive domains, the affected cognitive domains do not overlap completely.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  epidemiology; movement disorders; neurobehavioral manifestations; neuropsychological profile; neuropsychology

Mesh:

Year:  2017        PMID: 28261780      PMCID: PMC5585022          DOI: 10.1111/ane.12752

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  44 in total

1.  Cognitive and motor functional activity in non-demented community-dwelling essential tremor cases.

Authors:  Elan D Louis; Julián Benito-León; Saturio Vega-Quiroga; Félix Bermejo-Pareja
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-06-14       Impact factor: 10.154

2.  The World Health Organization cross-national research program on age-associated dementias.

Authors:  L Amaducci; M Baldereschi; M P Amato; A Lippi; P Nencini; S Maggi; J Litvak
Journal:  Aging (Milano)       Date:  1991-03

3.  Frontal lobe dysfunction in essential tremor: a preliminary study.

Authors:  M Gasparini; V Bonifati; E Fabrizio; G Fabbrini; L Brusa; G L Lenzi; G Meco
Journal:  J Neurol       Date:  2001-05       Impact factor: 4.849

4.  The neuropsychological assessment battery categories test as a measure of executive dysfunction in patients with Parkinson's disease and essential tremor: an exploratory study.

Authors:  Jared Benge; Jacqueline Phillips-Sabol; Richard Phenis
Journal:  Clin Neuropsychol       Date:  2014-09-02       Impact factor: 3.535

5.  Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

Authors:  Eva Pirogovsky; Dawn M Schiehser; Kristalyn M Obtera; Mathes M Burke; Stephanie L Lessig; David D Song; Irene Litvan; J Vincent Filoteo
Journal:  Neuropsychology       Date:  2014-01-13       Impact factor: 3.295

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Loss of independence in early Parkinson disease: A 5-year population-based incident cohort study.

Authors:  Anders Bjornestad; Ole-Bjorn Tysnes; Jan Petter Larsen; Guido Alves
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

8.  Evidence for distinct cognitive deficits after focal cerebellar lesions.

Authors:  B Gottwald; B Wilde; Z Mihajlovic; H M Mehdorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

9.  Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Authors:  A M Owen; M James; P N Leigh; B A Summers; C D Marsden; N P Quinn; K W Lange; T W Robbins
Journal:  Brain       Date:  1992-12       Impact factor: 13.501

10.  Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Tien K Khoo; David P Breen; Roger A Barker; Daniel Collerton; John-Paul Taylor; David J Burn
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

View more
  5 in total

1.  Rate of progression from mild cognitive impairment to dementia in an essential tremor cohort: A prospective, longitudinal study.

Authors:  Keith H Radler; Maria Anna Zdrodowska; Hollie Dowd; Tess E K Cersonsky; Edward D Huey; Stephanie Cosentino; Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2020-04-15       Impact factor: 4.891

Review 2.  Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.

Authors:  Katharine J Liang; Erik S Carlson
Journal:  Neurobiol Learn Mem       Date:  2019-01-07       Impact factor: 2.877

Review 3.  Mind the gaps: What we don't know about cognitive impairment in essential tremor.

Authors:  Elan D Louis; Jillian L Joyce; Stephanie Cosentino
Journal:  Parkinsonism Relat Disord       Date:  2019-03-01       Impact factor: 4.891

Review 4.  Essential Tremor and Parkinson's Disease: Exploring the Relationship.

Authors:  Arjun Tarakad; Joseph Jankovic
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-01-09

5.  Thalamic but Not Subthalamic Neuromodulation Simplifies Word Use in Spontaneous Language.

Authors:  Hannes Ole Tiedt; Felicitas Ehlen; Michelle Wyrobnik; Fabian Klostermann
Journal:  Front Hum Neurosci       Date:  2021-05-20       Impact factor: 3.169

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.